Assertio Therapeutics Q3 Adj. EPS $0.24, Inline, Sales $55.147M Miss $60.74M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.24 per share which met the analyst consensus estimate. This is a 42.86 percent decrease over earnings of $0.42 per share from the same period last

Benzinga · 11/06/2019 22:02

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.24 per share which met the analyst consensus estimate. This is a 42.86 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $55.147 million which missed the analyst consensus estimate of $60.74 million by 9.21 percent. This is a 28.84 percent decrease over sales of $77.493 million the same period last year.